Start your Trading & Investing Journey with us
Join our channel for Daily Free Trades with Live analysis on Youtube, Trade Setup with Important Levels, and Important Stock Market Updates
Medistep Healthcare IPO Review - Issue Date, Price, GMP, Subscription, Allotment, Lot Size, and Details
Medistep Healthcare IPO : Key Performance Indicators, PE Ratio, EPS, ROE, ROCE & RoNW
The Company Key Performance Indicates the pre-issue EPS of ₹ 4.01 and post-issue EPS of ₹ 2.92 for FY24. The pre-issue P/E ratio is 10.72x, while the post-issue P/E ratio is 14.74x against the Industry P/E ratio is 69x. The company's ROCE for FY24 is 38.91%, ROE for FY24 is 29.06% and RoNW is 24.62%. These metrics suggest that the IPO is fairly priced.
Key Performance Indicator
| KPI | Values |
|---|---|
| EPS Pre IPO (Rs.) | ₹ 4.01 |
| EPS Post IPO (Rs.) | ₹ 2.92 |
| Adjusted 12M EPS Post IPO (Rs.) | |
| P/E Pre IPO | 10.72 |
| P/E Post IPO | 14.74 |
| Adjusted 12M P/E Post IPO | |
| ROE | 29.06 % |
| ROCE | 38.91 % |
| P/BV | 1.86 |
| Debt/Equity | 0.04 |
| RoNW | 24.62 % |
| EBITDA Margin | |
| PAT Margin |
© 2022 CA Abhay Varn. All Rights Reserved Abhayvarn.com
